SCHEMBL29097261

SCHEMBL29097261

CC(C)(C)OC(=O)NC(COc1ccc2cnccc2c1Br)Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 11/20 0.48
▸ ATM Q13315 1/20 0.48
▸ AAK1 Q2M2I8 4/20 0.43
▸ HDAC3 O15379 1/20 0.42
▸ HDAC4 P56524 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC7 Q8WUI4 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC10 Q969S8 1/20 0.42
▸ HDAC11 Q96DB2 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ HDAC9 Q9UKV0 1/20 0.42
▸ HDAC5 Q9UQL6 1/20 0.42
▸ PRNP P04156 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ APP P05067 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30639635 1.00 CYP3A4 (0.48) CYP3A4ATMAAK1HDAC3HDAC4
SCHEMBL29828762 1.00 CYP3A4 (0.48) CYP3A4ATMAAK1HDAC3HDAC4
SCHEMBL27032731 0.89 CYP3A4 (0.48) CYP3A4ATMHDAC3HDAC4HDAC1
SCHEMBL27129004 0.89 CYP3A4 (0.48) CYP3A4ATMHDAC3HDAC4HDAC1
SCHEMBL27129786 0.88 PRNP (0.46) CYP3A4PRNPNPC1KCNH2POLB
SCHEMBL27032765 0.88 PRNP (0.46) CYP3A4PRNPNPC1KCNH2POLB
SCHEMBL29828650 0.88 CYP3A4 (0.47) CYP3A4ATMHDAC3HDAC4HDAC1
SCHEMBL29096836 0.88 CYP3A4 (0.47) CYP3A4ATMHDAC3HDAC4HDAC1
SCHEMBL30639506 0.88 CYP3A4 (0.47) CYP3A4ATMHDAC3HDAC4HDAC1
SCHEMBL29828809 0.86 ATM (0.47) CYP3A4ATMAAK1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116981672-A Macrocyclic compounds as CFTR modulators 爱杜西亚药品有限公司 2023-10-31 — — CN disclosed
Send feedback